Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 18, 2011
Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer's disease and other dementiasJean-Daniel Abraham, Sophie Calvayrac-Pawlowski, Sandra Cobo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 20, 2011
CCL20 is increased in hypercholesterolemic subjects and is upregulated by LDL in vascular smooth muscle cells: role of NF-κBOlivier Calvayrac, Ricardo Rodríguez-Calvo, Judith Alonso, et al.
Environmental Evidence|September 18, 2024
What are the toxicity thresholds of chemical pollutants for tropical reef-building corals? A systematic reviewDakis-Yaoba Ouédraogo, Hugo Mell, Olivier Perceval, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2026
Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLCSandra Ortiz-Cuaran, Laurine Dupriez, Constance Nicq, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2012
Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivoSara Martínez de Lizarrondo, Carmen Roncal, Olivier Calvayrac, et al.
EMBO Molecular Medicine|December 23, 2016
The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanismOlivier Calvayrac, Julien Mazières, Sarah Figarol, et al.
The Journal of Pathology|September 13, 2018
Cytoplasmic p27Olivier Calvayrac, Ada Nowosad, Stéphanie Cabantous, et al.
Nature Communications|June 27, 2024
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapiesSarah Figarol, Célia Delahaye, Rémi Gence, et al.
The Journal of Clinical Investigation|November 1, 2019
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinomaEmilie Bousquet Mur, Sara Bernardo, Laura Papon, et al.
Cell Reports. Medicine|August 2, 2024
In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAF<sup>V600E</sup> lung adenocarcinomaMarie-Julie Nokin, Elodie Darbo, Elodie Richard, et al.
Pageof 9